{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:45:11Z","timestamp":1793043911606,"version":"4.5.0"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec><jats:title>Objectives\/Hypothesis<\/jats:title><jats:p>The 22\u2010item Sinonasal Outcome Test (SNOT\u201022) is a validated chronic rhinosinusitis health\u2010related quality\u2010of\u2010life outcome (HRQoL) measure; however, SNOT\u201022 domains have not been validated specifically for chronic rhinosinusitis with nasal polyps (CRSwNP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design<\/jats:title><jats:p>Validation of SNOT\u201022 domain structure, using data from 3 randomized, placebo\u2010controlled, double\u2010blinded, multicenter clinical trials of dupilumab in adults with moderate\u2010to\u2010severe CRSwNP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Preliminary dimensional structure was derived by exploratory factor analyses of SNOT\u201022 data from a phase 2 trial (NCT01920893) of dupilumab for the treatment of CRSwNP. Data from 2 phase 3 clinical trials (NCT02912468 and NCT02898454) were then used for confirmatory factor analysis, and evaluated for reliability, construct validity, and responsiveness. In all three trials, the SNOT\u201022 was administered electronically on a tablet and trial participants were required to answer all items.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Factor analysis supported five domains: Nasal, Ear\/Facial, Sleep, Function, and Emotion. Correlations between domains were moderate to high, ranging from 0.53 (Nasal\u2013Emotion) to 0.88 (Function\u2013Sleep). Construct validity was mostly supported; relationships with other measures were almost always in the intended direction and magnitude. Internal consistency reliability also confirmed questionnaire structure with strong Cronbach's alpha values (all &gt;0.80). Moderate\u2010to\u2010high correlations were observed between change in SNOT\u201022 domain scores and other study patient\u2010reported outcome measures, along with large effect\u2010size estimates (\u22650.7), demonstrating responsiveness of the Nasal, Sleep, and Function domains. Emotion and Ear\/Facial domains had small\u2010to\u2010moderate effect sizes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Psychometric analyses support the validity, reliability, and responsiveness of five domains of SNOT\u201022 (Nasal, Ear\/Facial, Sleep, Function, and Emotion) for assessing symptoms and impact on HRQoL in patients with CRSwNP. <jats:italic>Laryngoscope<\/jats:italic>, 132:933\u2013941, 2022<\/jats:p><\/jats:sec>","DOI":"10.1002\/lary.29766","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T17:01:26Z","timestamp":1629997286000},"page":"933-941","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Development of Sinonasal Outcome Test (SNOT\u201022) Domains in Chronic Rhinosinusitis With Nasal Polyps"],"prefix":"10.1002","volume":"132","author":[{"given":"Asif H.","family":"Khan","sequence":"first","affiliation":[{"name":"Global Medical Affairs Immunology and Inflammation Development, Sanofi  Chilly\u2010Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Reaney","sequence":"additional","affiliation":[{"name":"Patient\u2010Centered Outcome Assessment RTI Health Solutions  Research Triangle Park North Carolina U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Guillemin","sequence":"additional","affiliation":[{"name":"Patient\u2010Centered Outcome Assessment RTI Health Solutions  Research Triangle Park North Carolina U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Nelson","sequence":"additional","affiliation":[{"name":"Patient\u2010Centered Outcome Assessment RTI Health Solutions  Research Triangle Park North Carolina U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Qin","sequence":"additional","affiliation":[{"name":"Patient\u2010Centered Outcome Assessment RTI Health Solutions  Research Triangle Park North Carolina U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhesh","family":"Kamat","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research Regeneron Pharmaceuticals, Inc.  Tarrytown New York U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Mannent","sequence":"additional","affiliation":[{"name":"Global Medical Affairs Immunology and Inflammation Development, Sanofi  Chilly\u2010Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Amin","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research Regeneron Pharmaceuticals, Inc.  Tarrytown New York U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Whalley","sequence":"additional","affiliation":[{"name":"Patient\u2010Centered Outcome Assessment RTI Health Solutions  Manchester U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[{"name":"ENT Department Guy's and St Thomas' NHS Foundation Trust  London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.32"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-013-2395-2"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.04.012"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.05.007"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin17.255"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-009-0031-4"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.23671"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhino50E2"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2007.06.726"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2009.01995.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26157"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.10.012"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-010-9606-8"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25108"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2013.06.033"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2014.1045"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21408"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-019-05320-z"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2015.29.4140"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22025"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/1945892420927244"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2012.02527.x"},{"key":"e_1_2_6_24_1","unstructured":"U.S. Food and Drug Administration.Guidance for Industry Patient\u2010Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims.https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims. Accessed September 14 2020."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13685"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"e_1_2_6_27_1","volume-title":"EQS Structural Equations Program Manual","author":"Bentler PM","year":"1989"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02291170"},{"key":"e_1_2_6_29_1","volume-title":"Testing Structural Equation Models","author":"Browne MW","year":"1993"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/10705519909540118"},{"key":"e_1_2_6_31_1","volume-title":"A Beginner's Guide to Structural Equation Modeling","author":"Schumacker RE","year":"1996"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02310555"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.1.1.30"},{"key":"e_1_2_6_34_1","volume-title":"Psychometric Theory","author":"Nunnally JC","year":"1994"},{"key":"e_1_2_6_35_1","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen J","year":"1988"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.11.037"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000540"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.12.021"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.401"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.11.013"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.02.023"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.29766","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/lary.29766","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.29766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T23:34:16Z","timestamp":1692488056000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lary.29766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1002\/lary.29766"],"URL":"https:\/\/doi.org\/10.1002\/lary.29766","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"2021-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}